0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

THE INTRAMENINGEAL TREATMENT OF TABES AND CEREBROSPINAL SYPHILIS

THOMAS R. BOGGS, M.D.; R. R. SNOWDEN, M.D.
Arch Intern Med (Chic). 1914;XIII(6):970-977. doi:10.1001/archinte.1914.00070120132011.
Text Size: A A A
Published online

The treatment of syphilis of the central nervous system has always been unsatisfactory. The cerebrospinal system is a closed one, and the diffusion of drugs from the circulating blood into the cerebrospinal fluid is slow and incomplete. For this reason organisms which have invaded the nervous tissue or meninges remain more or less protected from the drugs which may be present in the vascular system. For a number of years the desirability of the direct application of antisyphilitic drugs has been recognized. Horsley1 went so far as to advocate the "heroic" treatment of opening into the subdural space and washing out with mercuric chlorid (1:1,000) solution, but this procedure proved too irritating. With the advent of salvarsan and neosalvarsan, hope was entertained that this therapeutic agent could be injected intraspinally ; but investigation showed that it also damaged the tissues. Wechselmann2 found that small amounts (1 mg.) when

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();